Characteristic | No. 253 LN negative n = 2006 | No. 253 LN positive n = 112 | p-value |
---|---|---|---|
Age, years | 64.0 [56.0, 72.0] | 63.0 [56.8, 70.2] | 0.373 |
Sex, male | 1263 (63.0%) | 76 (67.9%) | 0.345 |
CEA, high | 735 (36.6%) | 78 (69.6%) | < 0.001 |
CA19-9, high | 219 (10.9%) | 31 (27.7%) | < 0.001 |
CA24-2, high | 419 (20.9%) | 49 (43.8%) | < 0.001 |
Tumor site |  |  | < 0.001 |
Rectum | 1388 (69.2%) | 58 (51.8%) | Â |
Sigmoid colon | 529 (26.4%) | 50 (44.6%) | Â |
Descending colon | 89 (4.44%) | 4 (3.57%) | Â |
Distance from anal verge, cm | 10.0 [6.00, 19.0] | 15.0 [10.0, 20.0] | < 0.001 |
Endoscopic obstruction, yes | 390 (19.4%) | 50 (44.6%) | < 0.001 |
Synchronous liver metastasis, yes | 62 (3.09%) | 10 (8.93%) | 0.004 |
Neoadjuvant, yes | 40 (1.99%) | 5 (4.46%) | 0.086 |
Intraoperative No. 253 LN enlargement, yes | 38 (1.89%) | 21 (18.8%) | < 0.001 |
LCA ligation level, high | 522 (26.0%) | 49 (43.8%) | < 0.001 |
Gross type | Â | Â | 0.002 |
Ulcerative | 1382 (68.9%) | 93 (83.0%) | Â |
Expanding/Infiltrative | 624 (31.1%) | 19 (16.9%) | Â |
Tumor differentiation |  |  | < 0.001 |
Well/moderately | 1782 (88.8%) | 79 (70.5%) | Â |
Poorly/undifferentiation | 224 (11.2%) | 33 (29.5%) | Â |
Pathological classification | Â | Â | 0.003 |
Adenocarcinoma/Mucinous adenocarcinoma | 2000 (99.7%) | 109 (97.3%) | Â |
Signet ring adenocarcinoma/Undifferentiated carcinoma | 6 (0.30%) | 3 (2.68%) | Â |
Neural invasion |  |  | < 0.001 |
Yes | 398 (19.8%) | 66 (58.9%) | Â |
No | 1543 (76.9%) | 44 (39.3%) | Â |
Not reported | 65 (3.24%) | 2 (1.79%) | Â |
Lymphovascular invasion |  |  | < 0.001 |
Yes | 254 (12.7%) | 43 (38.4%) | Â |
No | 1001 (49.9%) | 1 (0.89%) | Â |
Not reported | 751 (37.4%) | 68 (60.7%) | Â |
AJCC pT classification |  |  | < 0.001 |
T1 | 170 (8.47%) | 2 (1.79%) | Â |
T2 | 416 (20.7%) | 3 (2.68%) | Â |
T3 | 1291 (64.4%) | 81 (72.3%) | Â |
T4 | 129 (6.43%) | 26 (23.2%) | Â |
AJCC pN classification |  |  | < 0.001 |
N0 | 1162 (57.9%) | 0 (0.00%) | Â |
N1 | 578 (28.8%) | 25 (22.3%) | Â |
N2 | 266 (13.3%) | 87 (77.7%) | Â |